Idris, I. (2024). The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH). Wiley. https://doi.org/10.1002/doi2.92
Style de citation Chicago (17e éd.)Idris, Iskandar. The US Food and Drug Administration Has Approved Resmetirom as the First Drug to Treat Metabolic Dysfunction‐associated Steatohepatitis (MASH). Wiley, 2024. https://doi.org/10.1002/doi2.92.
Style de citation MLA (9e éd.)Idris, Iskandar. The US Food and Drug Administration Has Approved Resmetirom as the First Drug to Treat Metabolic Dysfunction‐associated Steatohepatitis (MASH). Wiley, 2024. https://doi.org/10.1002/doi2.92.
Attention : ces citations peuvent ne pas être correctes à 100%.